Dear participants,

I would like to warmly welcome you to the 2nd CME CNS conference in Athens. Actavis, the partner of this education, is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, branded generic, Over-the Counter (OTC) and biosimilar products.

The company is the third largest generic manufacturer in the U.S., holds a top 5 leadership position in nearly 20 international markets and our portfolio features more than 1,000 generics, branded generics, established brands and OTC products.

Actavis invests heavily in research and development, as well as in the education of healthcare professionals. An example of this activity will take place in the following days. I believe that this educational event will contribute to improving the healthcare in all countries concerned, and would like to wish you a fruitful meeting with inspiring lectures and motivating discussions.

With best regards,

Petr Kozel
Vice President S&M, Actavis Pharma International


2nd CME CNS, Athens

Athens, May 22-23, 2015

1st CME CNS 2014

Summary, lectures, archive


Live streaming and an online archive of the International Postgraduate Schools